VTYX
Ventyx Biosciences Inc
NASDAQ: VTYX · HEALTHCARE · BIOTECHNOLOGY
$14.00
+0.00% today
Updated 2026-03-04
Market cap
$1.00B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.49
Dividend yield
—
52W range
$1 – $15
Volume
4.1M
Ventyx Biosciences Inc (VTYX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+28.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+36.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.2%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-0.2%
2025-11-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-07 | $-0.32 | +28.9% | $9.26 | $9.24 | -0.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.45 | $-0.32 | +28.9% | — | — |
| 2025-06-30 | $-0.46 | $-0.38 | +17.4% | — | — |
| 2025-03-31 | $-0.69 | $-0.39 | +43.5% | — | — |
| 2024-12-31 | $-0.54 | $-0.41 | +24.3% | $1.45M | +34.6% |
| 2024-09-30 | $-0.52 | $-0.50 | +3.8% | — | — |
| 2024-06-30 | $-0.58 | $-0.45 | +22.4% | — | — |
| 2024-03-31 | $-0.69 | $-0.62 | +10.1% | — | — |
| 2023-12-31 | $-0.90 | $-0.79 | +12.2% | $1.08M | — |
| 2023-09-30 | $-0.90 | $-0.92 | -2.2% | — | — |
| 2023-06-30 | $-0.71 | $-0.91 | -28.2% | — | — |
| 2023-03-31 | $-0.65 | $-0.68 | -4.6% | — | — |
| 2022-12-31 | $-0.64 | $-0.62 | +3.1% | — | — |
Frequently asked questions
Has Ventyx Biosciences Inc beaten earnings estimates?
Ventyx Biosciences Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +28.5% over the last 4 quarters.
How does VTYX stock react to earnings?
VTYX stock has moved an average of -0.2% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.